162 related articles for article (PubMed ID: 12460458)
41. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
[TBL] [Abstract][Full Text] [Related]
42. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
[TBL] [Abstract][Full Text] [Related]
43. Adiponectin and colorectal adenomas: Self Defense Forces Health Study.
Fukumoto J; Otake T; Tajima O; Tabata S; Abe H; Mizoue T; Ohnaka K; Kono S
Cancer Sci; 2008 Apr; 99(4):781-6. PubMed ID: 18377427
[TBL] [Abstract][Full Text] [Related]
44. C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women.
Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):750-5. PubMed ID: 16614119
[TBL] [Abstract][Full Text] [Related]
45. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.
Renehan AG; Zwahlen M; Minder C; O'Dwyer ST; Shalet SM; Egger M
Lancet; 2004 Apr; 363(9418):1346-53. PubMed ID: 15110491
[TBL] [Abstract][Full Text] [Related]
46. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.
Chan JM; Stampfer MJ; Ma J; Gann P; Gaziano JM; Pollak M; Giovannucci E
J Natl Cancer Inst; 2002 Jul; 94(14):1099-106. PubMed ID: 12122101
[TBL] [Abstract][Full Text] [Related]
47. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
[TBL] [Abstract][Full Text] [Related]
48. Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study.
Szulc P; Joly-Pharaboz MO; Marchand F; Delmas PD
Calcif Tissue Int; 2004 Apr; 74(4):322-9. PubMed ID: 15255068
[TBL] [Abstract][Full Text] [Related]
49. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death.
Lin Y; Tamakoshi A; Kikuchi S; Yagyu K; Obata Y; Ishibashi T; Kawamura T; Inaba Y; Kurosawa M; Motohashi Y; Ohno Y
Int J Cancer; 2004 Jul; 110(4):584-8. PubMed ID: 15122592
[TBL] [Abstract][Full Text] [Related]
50. Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II.
Rice MS; Tamimi RM; Connolly JL; Collins LC; Shen D; Pollak MN; Rosner B; Hankinson SE; Tworoger SS
Breast Cancer Res; 2012 Mar; 14(2):R44. PubMed ID: 22414675
[TBL] [Abstract][Full Text] [Related]
51. Plasma insulin, glucose, IGF-I, IGF-II, and IGFBP-3 and risk of recurrent colorectal adenomas.
Kang M; Peery AF; Locklear C; Galanko JA; Sandler RS; Keku TO
J Gastroenterol Hepatol Res; 2013 Apr; 2(4):531-535. PubMed ID: 24533351
[TBL] [Abstract][Full Text] [Related]
52. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden.
Palmqvist R; Hallmans G; Rinaldi S; Biessy C; Stenling R; Riboli E; Kaaks R
Gut; 2002 May; 50(5):642-6. PubMed ID: 11950809
[TBL] [Abstract][Full Text] [Related]
53. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
[TBL] [Abstract][Full Text] [Related]
54. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.
Duron E; Funalot B; Brunel N; Coste J; Quinquis L; Viollet C; Belmin J; Jouanny P; Pasquier F; Treluyer JM; Epelbaum J; le Bouc Y; Hanon O
J Clin Endocrinol Metab; 2012 Dec; 97(12):4673-81. PubMed ID: 23015654
[TBL] [Abstract][Full Text] [Related]
55. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women.
Probst-Hensch NM; Wang H; Goh VH; Seow A; Lee HP; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):739-46. PubMed ID: 12917205
[TBL] [Abstract][Full Text] [Related]
56. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.
Allen NE; Key TJ; Appleby PN; Travis RC; Roddam AW; Rinaldi S; Egevad L; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjønneland A; Grønbaek H; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Berrino F; Mattiello A; Sacerdote C; Palli D; Quirós JR; Ardanaz E; Navarro C; Larrañaga N; Gonzalez C; Sanchez MJ; Trichopoulou A; Travezea C; Trichopoulos D; Jenab M; Ferrari P; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1121-7. PubMed ID: 17548673
[TBL] [Abstract][Full Text] [Related]
57. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
Drogan D; Schulze MB; Boeing H; Pischon T
Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
[TBL] [Abstract][Full Text] [Related]
58. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.
Yu H; Spitz MR; Mistry J; Gu J; Hong WK; Wu X
J Natl Cancer Inst; 1999 Jan; 91(2):151-6. PubMed ID: 9923856
[TBL] [Abstract][Full Text] [Related]
59. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
60. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S
Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
